Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

specialist sales pty ltd - ivermectin - topical solution/suspension - ivermectin anthelmintic active 5.0 g/l - parasiticides

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

nutrien ag solutions limited - alpha-cypermethrin; liquid hydrocarbons present as liquid paraffin - emulsifiable concentrate - alpha-cypermethrin pyrethroid active 100.0 g/l; liquid hydrocarbons present as liquid paraffin ungrouped other 755.0 g/l - insecticide

Ireland - English - HPRA (Health Products Regulatory Authority)

laboratorios hipra s.a. - eimeria acervulina, strain 003; eimeria maxima, strain 013; eimeria mitis, strain 006; eimeria praecox, strain 007; eimeria tenella, strain 004 - oral suspension - . - coccidia - chickens - immunological - live vaccine

Australia - English - Department of Health (Therapeutic Goods Administration)

3m australia pty ltd - 58302 - antimicrobial synthetic polymer semi-permeable film dressing, adhesive - picc/cvc securement device + tegaderm chg drsg can be used to cover and protect catheter sites and to secure devices to skin. common applications include central venous and arterial catheters, other intravascular catheters and percutaneous devices. it is intended to reduce skin colonisation and catheter colonisation and to suppress growth of microorganisms commonly related to blood stream infections (crbsi). the 3m tegaderm chg chlorhexidine gluconate iv securement dressing and the picc/cvc securement device are used together to cover and protect catheter sites and used to secure peripherally inserted central catheters (piccs) and short term central venous catheters (cvcs) to the skin. the tegaderm chg dressing is intended to reduce skin colonization and catheter colonization and to suppress regrowth of microorganisms commonly related to bloodstream infections and is intended to reduce catheter related bloodstream infections (crbsi) in patients with central venous or arterial catheters.

Australia - English - Department of Health (Therapeutic Goods Administration)

life healthcare pty ltd - 61006 - humeral stem extension prosthesis - composed of tial6v4 with silver coating. combines the mutars humerus connection part with the mutars humerus extension piece or mutars humerus head with the mutars distal humerus. the reducer utilizes the mutars cylindrical fit and serration connection design for attachment to the mutars humerus head, humerus extension piece, humerus connecting part, humerus stem, distal humerus, proximal ulna. a component of the mutars system intended to provide extraosseous length adjustment in cases of a total humerus replacement. primary indication for the use of the mutars systems is after bone resection because of a tumour. further indications for the use of the mutars systems are massive bone loss such as in morbus gorham or for the revision arthroplasty and for the prosthetic treatment in case of fractures, pseudarthrosis and arthrosis. the silver coated surface builds a long term prophylaxis against the colonisation of human pathogenic bacteria such as staphylococcus aureus and epidermis, exclusive enterobacteriae and should not be considered as acute treatment.

Australia - English - Department of Health (Therapeutic Goods Administration)

life healthcare pty ltd - 58085 - knee arthrodesis prosthesis - composed of tial6v4 with silver coating. tibial part of a two part arthrodesis for bridging the knee joint. to be combined with the mutars rs arthrodesis implant femoral component via two screws & 2 boreholes (diam. 8.5 mm). 50 mm in ml, 37 mm in ap with height of 52.5 mm. utilizes the female mutars taper connection design for attachment to the rs stem. a component of the mutars system intended to serve as part of a fused (non-articulating) replacement for the knee joint intended to be implanted after failed primary knee arthroplasty and which functions as a bridge between the resected metaphyses of the femur and tibia. arthrodesis implants are indicated, in the case of - massive bone loss with insufficient skin and soft tissue coverage because of tumors, revisions, fractures or morbus gorham. - a deficit extensor mechanism. the silver coated surface builds a long term prophylaxis against the colonisation of human pathogenic bacteria such as staphylococcus aureus and epidermis, exclusive enterobacteriae and should not be considered as acute treatment.

Australia - English - Department of Health (Therapeutic Goods Administration)

life healthcare pty ltd - 58085 - knee arthrodesis prosthesis - composed of tial6v4 with silver coating. femoral part of a two part arthrodesis for bridging the knee joint. to be combined with the mutars rs arthrodesis implant tibial component via two screws & 2 boreholes (diam. 8.5 mm). 50 mm in ml, 37 mm in ap with height of 53.4 mm. utilizes the female mutars taper connection design for attachment to the rs stem. the component incorporates angle of 7 degrees between the rotation and femoral axis to match the anatomical femoral-tibial angle. a component of the mutars system intended to serve as part of a fused (non-articulating) replacement for the knee joint intended to be implanted after failed primary knee arthroplasty and which functions as a bridge between the resected metaphyses of the femur and tibia. arthrodesis implants are indicated, in the case of - massive bone loss with insufficient skin and soft tissue coverage because of tumors, revisions, fractures or morbus gorham. - a deficit extensor mechanism. the silver coated surface builds a long term prophylaxis against the colonisation of human pathogenic bacteria such as staphylococcus aureus and epidermis, exclusive enterobacteriae and should not be considered as acute treatment.

Australia - English - Department of Health (Therapeutic Goods Administration)

life healthcare pty ltd - 61561 - body femoral/tibial extension stem, uncoated - composed of tial6v4 with silver coating. provides coupling of a component with a mutars taper connection to a component with a mutars cylindrical fit connection. it has a male mutars cylindrical and serration connection at one end and a female mutars taper connection at the other end. the coupling is 28 mm in diameter and 30 mm in length. an 8 mm diameter internal mutars coupling device screw is applied across the connection to secure the connection. a component of the mutars system intended to provide an adapter coupling between components in the femoral region. primary indication for the use of the mutars systems is after bone resection because of a tumour. further indications for the use of the mutars systems are massive bone loss such as in morbus gorham or for the revision arthroplasty and for the prosthetic treatment in case of fractures, pseudarthrosis and arthrosis. the silver coated surface builds a long term prophylaxis against the colonisation of human pathogenic bacteria such as staphylococcus aureus and epidermis, exclusive enterobacteriae and should not be considered as acute treatment.

Australia - English - Department of Health (Therapeutic Goods Administration)

life healthcare pty ltd - 43167 - acetabular shell - tial6v4 with silver coating. the mutars (modular universal tumor & revision system) lumic system is a modular acetabular reconstruction system, which relieves patients from pain and limited mobility after massive acetabular bone loss or severe acetabular defects. connects to various lumic stems and inserts, the lumic cup can be rotated in 5 degree increments to prevent luxation. in order to adjust the rotation for optimal stability, first the proximal femur replacement should be performed. an acetabular component of the mutars lumic system used in partial pelvic reconstruction replacement for the hip joint after many or complicated revisions or after major bone defects of the acetabulum. primary indication for the use of the mutars lumic system is after bone resection because of a tumour (peri acetabular tumours). further indications for the use of the mutars lumic system are massive bone loss such as in morbus gorham or for the revision arthroplasty and for the prosthetic treatment in case of fractures, pseudarthrosis and arthrosis. the silver coated surface builds a long term prophylaxis against the colonisation of human pathogenic bacteria such as staphylococcus aureus and epidermis, exclusive enterobacteriae and should not be considered as acute treatment.

Australia - English - Department of Health (Therapeutic Goods Administration)

life healthcare pty ltd - 32831 - uncoated knee femur prosthesis - constructed of cocrmo with titanium nitride and silver coating. kri ? knee reconstruction implant is a constrained revision knee implant that replaces the distal femoral condyles. connects with various stems and extension pieces as part of the modular universal tumour and revision system (mutars). connects to the tibial plateau using the locking mechanism m-o-m. a femoral condyle replacement component of the mutars system used as part of a total knee replacement. primary indication for the use of the mutars systems is after bone resection because of a tumour. further indications for the use of the mutars systems are massive bone loss such as in morbus gorham or for the revision arthroplasty and for the prosthetic treatment in case of fractures, pseudarthrosis and arthrosis. the silver coated surface builds a long term prophylaxis against the colonisation of human pathogenic bacteria such as staphylococcus aureus and epidermis, exclusive enterobacteriae and should not be considered as acute treatment.